tiprankstipranks
Atara Biotherapeutics (ATRA)
NASDAQ:ATRA
US Market

Atara Biotherapeutics (ATRA) Income Statement

Compare
1,135 Followers

Atara Biotherapeutics Income Statement

Last quarter (Q3 2024), Atara Biotherapeutics's total revenue was $40.19M, an increase of 1779.79% from the same quarter last year. In Q3, Atara Biotherapeutics's net income was $-21.91M. See Atara Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 8.57M$ 63.57M$ 20.34M$ 0.00$ 0.00
Gross Profit
$ -313.00K$ 49.01M$ 8.96M$ -9.87M$ -8.11M
Operating Expenses
$ 275.69M$ 344.09M$ 360.80M$ 309.05M$ 295.68M
Depreciation and Amortization
$ 4.83M$ 14.57M$ 11.38M$ 9.87M$ 8.11M
EBITDA
$ -266.00M$ -213.72M$ -331.12M$ -296.74M$ -282.86M
Operating Income
$ -276.01M$ -280.51M$ -340.46M$ -309.05M$ -295.68M
Other Income/Expenses
$ -105.00K$ 52.22M$ 367.00K$ 2.45M$ 4.72M
Pretax Income
$ -276.11M$ -228.29M$ -340.10M$ -306.61M$ -290.96M
Net Income
$ -276.13M$ -2.28B$ -3.40B$ -3.07B$ -2.91B
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -65.18$ -55.96$ -90.78$ -103.63$ -141.78
Diluted EPS
$ -65.18$ -55.96$ -90.78$ -103.63$ -141.78
Weighted Average Shares Outstanding
4.24M 4.08M 3.75M 2.96M 2.05M
Weighted Average Shares Outstanding (Diluted)
4.24M 4.08M 3.75M 2.96M 2.05M
Currency in USD

Atara Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis